Johnson & Johnson (JNJ)

163.30
+1.96(+1.21%)
  • Volume:
    1,338
  • Bid/Ask:
    163.08/163.30
  • Day's Range:
    160.80 - 163.30

JNJ Overview

Prev. Close
161.34
Day's Range
160.8-163.3
Revenue
-
Open
162
52 wk Range
134.04-178
EPS
6.98
Volume
1,338
Market Cap
429.12B
Dividend (Yield)
4.52
(2.73%)
Average Vol. (3m)
657
P/E Ratio
24.91
Beta
0.589
1-Year Change
8.18%
Shares Outstanding
2,629,179,895
Next Earnings Date
-
What is your sentiment on J&J?
or
Vote to see community's results!

Johnson & Johnson News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Johnson & Johnson Analysis

Johnson & Johnson Company Profile

Johnson & Johnson Company Profile

Employees
141700
  • Type:Equity
  • Market:Germany
  • ISIN:US4781601046
  • WKN:853260

Johnson & Johnson is a holding company that is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates through three segments: Consumer Health, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellStrong SellBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Buy
SummaryBuyNeutralNeutralStrong SellStrong Buy
  • i would say sisnce it already broke the 168 level of structure i would be hunting for the liquidity at 155-156 and that would be my target.
    0
    • is anybody else seeing a big head and shoulders on the daily chart as I am honestly looking for some feedback rather than making any claim one way or the other. Thanks in advance folks.
      0
      • first 155, after 140 target:))
        4
        • R u crazy
          0
      • 175,5 target!
        0
        • vaccines are problematic. High penalties will come from lawsuits. stock markets are falling. However, the stock is going up. god *****share
          4
          • Tomorrow is earnings report . Let wait for report.. if below forcast we can short it on cfd ... Also the company is paying $99m to West Virginia..... That a negative report I guess...
            4
            • I want to buy
              2
              • JnJ is buy and hold dude, enjoy divis. It grows slowly in a sustainable way
                1
                • thought tho that jnj will be on a good buy this season as they are about to improve on there vaccines
                  0
                  • to buy or not?????
                    1